FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2022
Back to search
Official data from USPTO
QIQU MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QIQU MEDICAL
ST13
US500000079320216Class
3, 5
Filing
79320216
Registration
6816972
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/21/2022
Trademark type
Word
Nice classes
3, 5
Filing date
05/03/2021
Registration date
08/16/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2022
Last transaction
08/16/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
VAGHANI, MAYUR C
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Medoderm GmbH
Representatives
Mark J. Liss Leydig, Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetics; non-medicated toiletry preparations; non-medicated skin care preparations; hair preparations and treatments for cosmetic purposesspraysgelsfoams; non-medicated scalp care preparationscosmetic preparations for the scalp; cleaning and cosmetic preparations for protection against contact allergies; cleaning and cosmetic preparations for the prevention of contact allergies; cleaning and cosmetic preparations for the differential stabilisation of skin flora; cosmetic preparations for covering surfaces in the nature of skin for the prevention of contact allergies
Class 5
Medicated preparations for treating skin diseasesincluding mucous membrane disorders and preparations for treating insect bites; medical plastersmaterials for dressingsmedical products for healing wounds and alleviating the symptoms of diseased skin in the form of solidsemi-liquid and liquid medicated patches; medical products for healing wounds and alleviating the symptoms of diseased skinmedicated skin care preparations; medicated skin care preparations; medicated skin lotions; medicated preparations for skin treatment; pharmaceutical preparations for treating skin disorders; biocides; medicated preparations for the treatment and care of woundsskin injuriesburns and surgical wounds; medicated preparations for protection against contact allergies; medicated preparations for the prevention of contact allergiesmedicated preparations for the differential stabilisation of skin flora; transdermal patches for use in the treatment of allergy symptoms; gel for external usefor the medical and therapeutic treatment of allergy symptoms; antimicrobial coatings to treat the growth of virusesmoldmildewbacteria and fungus on various surfacesfor the prevention of contact allergies
Publications
History of USPTO decisions and trademark events.
27 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/29/2022
FIMP
FINAL DISPOSITION PROCESSED
11/28/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/16/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/16/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2022
PUBO
PUBLISHED FOR OPPOSITION
05/31/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
04/25/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/25/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
04/25/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/24/2022
RFNT
REFUSAL PROCESSED BY IB
02/20/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/31/2022
RFRR
REFUSAL PROCESSED BY MPU
01/31/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/11/2022
CNRT
NON-FINAL ACTION WRITTEN
01/10/2022
DOCK
ASSIGNED TO EXAMINER
01/05/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/24/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/20/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/16/2021
Continuous trademark protection
Get notified about every new filing that threatens QIQU MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.